Playback speed
10 seconds
ASH 2023 Insights: "Revumenib Monotherapy in Pts With R/R KMT2Ar Acute Leukemia From the AUGMENT-101 Study"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Ibrahim Aldoss
By
Insights from 2023 ASH Annual Meeting
FEATURING
Ibrahim Aldoss
83 views
December 29, 2023
Login to view comments.
Click here to Login